Dan Troy

Dan Troy is a managing director at BRG, who serves as an expert witness in a variety of disputes. His past experience includes working as Chief Counsel for the US Food and Drug Administration (FDA) during the George W. Bush administration and General Counsel of GlaxoSmithKline.

Mr. Troy has testified in cases involving Hatch-Waxman regulations, reverse payments, punitive damages, corporate governance, trade secrets, drug and device regulation, product liability, and other related topics. He has testified in court numerous times for the winning side, and his testimony has been favorably cited or relied on in every case, including the Lipitor reverse payment case.

Mr. Troy has been a partner in two national law firms, chair of the American Bar Association Section of Administrative Law and Regulatory Practice and of the Chamber of Commerce Litigation Center. He is a member of the American Law Institute and has been a member of the Administrative Conference of the United States.

Mr. Troy was named a “Legend in the Law” at the 2013 Burton Awards and selected in the Financial Times (FT) Global General Counsel 30 in 2016. He is a graduate of Columbia Law School and the Cornell School of Industrial and Labor Relations and clerked for D.C. Circuit Judge Robert Bork.